Revenue

12 Months Ended

Sep. 30, 2021

Revenue From Contract With Customer [Abstract]

Revenue

NOTE Q – REVENUE

Trade receivables

Trade receivables are defined as receivables arising from contracts with customers and are recorded within the accounts receivable caption within the Consolidated Balance Sheets. Ashland’s trade receivables were $308 million and $400 million as of September 30, 2021 and September 30, 2020, respectively. See Note I for additional information on Ashland's program to sell certain receivables on a revolving basis to third party banks up to an aggregate purchase limit.

Disaggregation of revenue

Ashland disaggregates its revenue from contracts with customers by segment and geographical region, as Ashland believes these categories best depict how management reviews the financial performance of its operations for the twelve months ended September 30, 2021, 2020 and 2019. Ashland includes only U.S. and Canada in its North America designation. See the following tables for details (Intersegment sales eliminations have been excluded. See Note R for additional information.)

Sales by geography
(In millions)	2021		2020		2019
Life Sciences
North America	$	229	$	226	$	252
Europe		242		229		226
Asia Pacific		192		181		182
Latin America & other		74		72		72
	$	737	$	708	$	732
(In millions)	2021		2020		2019
Personal Care & Household
North America	$	180	$	185	$	182
Europe		240		258		280
Asia Pacific		100		97		109
Latin America & other		72		75		80
	$	592	$	615	$	651
(In millions)	2021		2020		2019
Specialty Additives
North America	$	203	$	199	$	218
Europe		246		218		237
Asia Pacific		171		134		160
Latin America & other		35		38		39
	$	655	$	589	$	654
(In millions)	2021		2020		2019
Intermediates and Solvents
North America	$	114	$	73	$	107
Europe		28		24		23
Asia Pacific		29		26		25
Latin America & other		7		6		5
	$	178	$	129	$	160

For fiscal 2021, Ashland had two product categories that represented 10% or greater of Ashland's total consolidated sales which were cellulosics representing 39% of total consolidated sales and polyvinylprrolidones (PVP) representing 19% of total consolidated sales.